Optical Brightening Agent BA-550 | CAS:4193-55-9

We serve Optical Brightening Agent BA-550 CAS:4193-55-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Optical Brightening Agent BA-550

Optical Brightening Agent BA-550
 
Main composition
C.I.No:113
CAS No:4193-55-9
Molecular mass:960
Formula:C40H42N12O10S2Na2
Type of product:Mixture substance
 
Technical index  
Appearance:Yellow-greenish Granule
pH Value:6.0~8.0
E  Value(±20):550
Ionic character:anionic
 
Performance and Features  
1.Convenient in application, suitable for continuous addition。
2.Good fluorescent whitening performance in the pulp, surface sizing and coating processes.
 
Application Methods:
1.Convenient in application, diluted with water.
2.It can be directly added into the paper pulp, but in the course of adding, should avoid adding together with the other cationic chemicals or directly contact, mix. Adding in the pulp, the proportion based on weight of between OBA and absolute dry paper pulp is 0.03％～1.0％。
3.It can be used in cotton, dosage: 0.05-0.4% (o.w.f.); Liquor ratio: 1:10-30; Temperature: 80℃~100℃；30~60min ;
 
Packaging and Storage  
Packaging with 25kg bag, or special packaging according to customers, more than two years of stability，store at the room temperature.



Contact us for information like Optical Brightening Agent BA-550 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Optical Brightening Agent BA-550 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Optical Brightening Agent BA-550 Use and application,Optical Brightening Agent BA-550 technical grade,usp/ep/jp grade.


Related News: This time frame optimizes the opportunity to respond to treatment with an HMA prior to declaring treatment failure, as per NCCN Guidelines. Patients are randomized at a 2:1 ratio into two study arms: IV rigosertib plus Best Supportive Care versus Physician’s Choice plus Best Supportive Care.DL-1,2-Isopropylideneglycerol manufacturer This time frame optimizes the opportunity to respond to treatment with an HMA prior to declaring treatment failure, as per NCCN Guidelines. Patients are randomized at a 2:1 ratio into two study arms: IV rigosertib plus Best Supportive Care versus Physician’s Choice plus Best Supportive Care.Tetramethyldisiloxane supplier At present, the additional 300 tons of sunniamine, 300 tons of fluoxamic acid, and 200 tons of cyprodinil have been successfully put into production, and the profitability is good.3-Fluoro-4-nitrobenzoic acid vendor At present, the additional 300 tons of sunniamine, 300 tons of fluoxamic acid, and 200 tons of cyprodinil have been successfully put into production, and the profitability is good.Amid mounting public skepticism over the effectiveness of Shuanghuanglian, the ruling Communist Party’s mouthpiece, the People’s Daily, warned Saturday morning that “inhibiting does not equal preventing and treating,” reminding the public not to rush to purchase the herbal remedy, or take it without medical supervision.